New and Existing Patients
Already a patient?
Login or sign-upto Connect Patient Portal to make an appointment

A Phase 3 Trial of Brepocitinib in Dermatomyositis.
NXP-2-positive dermatomyositis presenting with pronounced unilateral lower extremity subcutaneous edema.
30-day readmission after total hip and knee arthroplasty in patients with systemic lupus erythematosus: A US nationwide study.